Results 51 to 60 of about 301,814 (290)

Detecting population III galaxies with HST and JWST

open access: yes, 2012
A small fraction of the atomic-cooling halos assembling at ...
Zackrisson, E.
core   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

WHERE ARE THE LOW-MASS POPULATION III STARS? [PDF]

open access: yesThe Astrophysical Journal, 2016
ABSTRACT We study the number and the distribution of low-mass Population III (Pop III) stars in the Milky Way. In our numerical model, hierarchical formation of dark matter minihalos and Milky-Way-sized halos are followed by a high-resolution cosmological simulation.
Tomoaki Ishiyama   +5 more
openaire   +2 more sources

The Contribution of the First Stars to the Cosmic Infrared Background [PDF]

open access: yes, 2001
We calculate the contribution to the cosmic infrared background from very massive metal-free stars at high redshift. We explore two plausible star-formation models and two limiting cases for the reprocessing of the ionizing stellar emission. We find that
Callaway   +4 more
core   +5 more sources

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Detecting Population III Stars through Tidal Disruption Events in the Era of JWST and Roman

open access: yesThe Astrophysical Journal Letters
The first-generation metal-free stars, referred to as Population III (Pop III) stars, are believed to be the first objects to form out of the pristine gas in the very early Universe.
Rudrani Kar Chowdhury   +3 more
doaj   +1 more source

Intermediate-mass black holes and contribution to extragalactic background light from Population III stars in Milky Way-like galaxies

open access: yesAstronomy & Astrophysics
The mass range of observed black holes extends from stellar-mass to supermassive scales, yet the existence of objects in the intermediate-mass range of 102–105 M⊙ remains unconfirmed.
Mkrtchyan A., Horns D.
doaj   +1 more source

Revisiting The First Galaxies: The epoch of Population III stars

open access: yes, 2013
We investigate the transition from primordial Population III (Pop III) star formation to normal Pop II star formation in the first galaxies using new cosmological hydrodynamic simulations.
Gnedin, Nickolay Y.   +3 more
core   +1 more source

THE MOST IRON-DEFICIENT STARS AS THE POLLUTED POPULATION III STARS [PDF]

open access: yesThe Astrophysical Journal, 2015
Accepted for publication in ApJ ...
Yutaka Komiya   +2 more
openaire   +2 more sources

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy